...Good morning. I'm Nelli Mainolfi, President and CEO of Kymera Therapeutics, and I will act as Chairperson of this meeting. I'm pleased to welcome you to Kymera Therapeutics' 2025 Annual Meeting of Shareholders. Before I call the meeting to order, I would like to introduce you to the members of our Board and executive team who are with us today. The other members of the Board with us today are Mr. Jeff Albers, Dr. Felix Baker, Dr. Bruce Booth, Dr. Pamela Esposito, Dr. Gorjan Hrustanovic, Dr. John Maraganore, Ms. Elena Ridloff, Dr. Victor Sandor. The other executive officers of the corporations with us today are Dr. Jeremy Chadwick, our Chief Operating Officer; Ms. Ellen Chiniara, our Chief Legal Officer and Corporate Secretary; Dr. Jared Gollob, our Chief Medical Officer; Mr. Noah Goodman, our Chief Business Officer; and Mr. Bruce Jacobs, our Chief Financial Officer. I would also like to introduce Brendan McCorry of Ernst & Young, the corporation's independent registered public accounting...